Important Information for ModivCare Securities Purchasers: Class Action Lawsuit and Deadline Reminder
Rosen Law Firm, a leading global investor rights law firm, is reminding investors of their potential eligibility to participate in a securities class action lawsuit against ModivCare Inc. (MODV). The lawsuit alleges that ModivCare and certain of its officers and directors violated the Securities Exchange Act of 1934 between November 3, 2022, and September 15, 2024 (the “Class Period”).
What Happened?
ModivCare is a technology-enabled healthcare company that provides personalized solutions for post-acute care at home. The company’s stock was traded on the NASDAQ under the symbol MODV. During the Class Period, ModivCare issued materially misleading statements regarding its business, operations, and financial results.
Why Does This Matter?
If you purchased ModivCare securities during the Class Period, you may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement. The lead plaintiff deadline in this case is March 31, 2025.
What’s Next?
If you wish to serve as lead plaintiff, you must move the Court no later than March 31, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation as a class member or wish to learn more about the case, please contact the Rosen Law Firm as soon as possible.
Impact on Individual Investors
If you purchased ModivCare securities during the Class Period, you may have suffered financial losses as a result of the defendants’ misrepresentations. The class action lawsuit aims to recover damages for these losses. If successful, investors may be entitled to compensation.
Impact on the World
The securities class action lawsuit against ModivCare serves as a reminder of the importance of transparency and accuracy in financial reporting. Companies and their executives have a responsibility to provide truthful and complete information to investors. Misrepresentations can lead to significant financial losses for investors and undermine confidence in the securities markets. Class action lawsuits like this one help to hold companies and their executives accountable for their actions and provide a means for investors to seek compensation for their losses.
Conclusion
If you purchased ModivCare securities during the Class Period and believe you may have suffered financial losses as a result of the defendants’ misrepresentations, you may be entitled to compensation. The lead plaintiff deadline in this case is March 31, 2025. Contact the Rosen Law Firm as soon as possible for more information about the case and how you can participate.
- Rosen Law Firm reminds ModivCare securities purchasers of the March 31, 2025, lead plaintiff deadline
- Investors may be entitled to compensation without payment of any out-of-pocket fees or costs
- The lawsuit alleges that ModivCare and certain officers and directors violated the Securities Exchange Act of 1934
- Impact on individual investors: potential for financial compensation
- Impact on the world: importance of transparency and accuracy in financial reporting
